Memphasys Ltd Asset Resilience Ratio
Memphasys Ltd asset resilience ratio. Memphasys Ltd (MEM) has an Asset Resilience Ratio of 0.00% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See MEM days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Memphasys Ltd (2015–2024)
Asset resilience ratio of Memphasys Ltd from 2015 to 2024. This chart shows how Memphasys Ltd's Asset Resilience Ratio has changed over time. Read MEM total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Memphasys Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Memphasys Ltd's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Memphasys Ltd maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Memphasys Ltd Industry Peers by Asset Resilience Ratio
Compare Memphasys Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Ningbo David Medical Device Co Ltd
SHE:300314 |
Medical Devices | 5.11% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 15.99% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Nova EYE Medical Ltd
AU:EYE |
Medical Devices | 11.08% |
|
Promimic AB
ST:PRO |
Medical Devices | 8.62% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
Memphasys Ltd Asset Resilience Ratio by Year (2015–2024)
Memphasys Ltd asset resilience ratio by year from 2015 to 2024. The table below shows the annual Asset Resilience Ratio data for Memphasys Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$12.43 Million ≈ $8.80 Million |
-- |
| 2023-06-30 | 0.29% | AU$42.75K ≈ $30.25K |
AU$14.67 Million ≈ $10.38 Million |
-4.49pp |
| 2018-06-30 | 4.79% | AU$201.81K ≈ $142.79K |
AU$4.22 Million ≈ $2.98 Million |
-47.63pp |
| 2017-06-30 | 52.42% | AU$3.83 Million ≈ $2.71 Million |
AU$7.30 Million ≈ $5.17 Million |
+51.82pp |
| 2016-06-30 | 0.59% | AU$42.74K ≈ $30.24K |
AU$7.19 Million ≈ $5.09 Million |
+0.04pp |
| 2015-06-30 | 0.56% | AU$38.00K ≈ $26.89K |
AU$6.84 Million ≈ $4.84 Million |
-- |
About Memphasys Ltd
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port… Read more